Channel Infrastructure NZ Limited logo

SSH Notice – BP NZ Holdings Ltd, Europa Oil Ltd

Substantial Holder Notice17 March 2017CHIEnergy

20533071
Disclosure of change in nature of relevant interest

Section 278, Financial Markets Conduct Act 2013

To NZX Limited

and

To The New Zealand Refining Company Limited

Relevant event being disclosed: Change in nature of relevant interest

Date of relevant event: 17 March 2017

Date this disclosure made: 17 March 2017

Date last disclosure made: 6 March 2014

Substantial product holders giving disclosure

Full names: BP New Zealand Holdings Limited, Europa Oil NZ Limited

Summary of substantial holding

Class of quoted voting products: Ordinary Shares (NZX code: NZR)

Summary for BP New Zealand Holdings Limited and Europa Oil NZ Limited

For this disclosure,—

(a) total number held in class: 66,240,021 Ordinary Shares

(b) total in class: 312,576,453 Ordinary Shares

(c) total percentage held in class: 21.192%

For last disclosure,—

(a) total number held in class: 66,240,021

(b) total in class: 308,572,758

(c) total percentage held in class: 21.467%

Details of transactions and events giving rise to relevant event

Details of the transactions or other events requiring disclosure: On 16 March 2017, BP

New Zealand Holdings Limited and Europa Oil NZ Limited entered into a block trade

agreement (attached, 16 pages) with Deutsche Craigs Limited, under which BP New

Zealand Holdings Limited and Europa Oil NZ Limited agreed to sell, and Deutsche Craigs

Limited agreed to use best endeavours to procure the sale of, up to 34,667,381 Ordinary

Shares in The New Zealand Refining Company Limited held by BP New Zealand Holdings

Limited and its wholly-owned subsidiary, Europa Oil NZ Limited, at a sale price of at least

NZ$2.30 per share.

Pursuant to that agreement, 10,667,367 Ordinary Shares held by BP New Zealand Holdings

Limited and 24,000,014 Ordinary Shares held by Europa Oil NZ Limited have been



20533071

allocated to investors, at a sale price of NZ$2.32 per Ordinary Share, with settlement

expected to occur on 21 March 2017. As a consequence of those allocations, there is a

qualification on the power of BP New Zealand Holdings Limited and Europa Oil NZ Limited

to dispose of, or control the disposal of, such shares.

Details after relevant event

Details for BP New Zealand Holdings Limited

Nature of relevant interest: BP New Zealand Holdings Limited is the registered holder and

beneficial owner of 42,240,007 Ordinary Shares.

For that relevant interest,—

(a) number held in class: 42,240,007

(b) percentage held in class: 13.513%

(c) current registered holder: BP New Zealand Holdings Limited

(d) registered holder once transfers are registered: N/A

Nature of relevant interest: Europa Oil NZ Limited is the registered holder and beneficial

owner of 24,000,014 Ordinary Shares, and is a wholly-owned subsidiary of BP New

Zealand Holdings Limited. BP New Zealand Holdings Limited has a relevant interest in

those Ordinary Shares under section 237(b) of the Financial Markets Conduct Act 2013.

For that relevant interest,—

(a) number held in class: 24,000,014

(b) percentage held in class: 7.678%

(c) current registered holder: Europa Oil NZ Limited

(d) registered holder once transfers are registered: N/A

Details for Europa Oil NZ Limited

Nature of relevant interest: BP New Zealand Holdings Limited is the registered holder and

beneficial owner of 42,240,007 Ordinary Shares. As a wholly-owned subsidiary of BP New

Zealand Holdings Limited, Europa Oil NZ Limited has a relevant interest in those Ordinary

Shares under section 237(d) of the Financial Markets Conduct Act 2013

For that relevant interest,—

(a) number held in class: 42,240,007

(b) percentage held in class: 13.513%

(c) current registered holder: BP New Zealand Holdings Limited

(d) registered holder once transfers are registered: N/A



20533071

Nature of relevant interest: Europa Oil NZ Limited is the registered holder and beneficial

owner of 24,000,014 Ordinary Shares

For that relevant interest,—

(a) number held in class: 24,000,014

(b) percentage held in class: 7.678%

(c) current registered holder: Europa Oil NZ Limited

(d) registered holder once transfers are registered: N/A

Additional information

Addresses of substantial product holders: Watercare House, 73 Remuera Road,

Newmarket, Auckland, 1050, New Zealand

Contact details: Rachael Lynch, Phone: +64 21 893 884, Email: rachael.lynch@bp.com

Nature of connection between substantial product holders: Europa Oil NZ Limited is a

wholly-owned subsidiary of BP New Zealand Holdings Limited

Name of any other person believed to have given, or believed to be required to give, a

disclosure under the Financial Markets Conduct Act 2013 in relation to the financial

products to which this disclosure relates: N/A

Certification

I, Rachael Lynch, certify that, to the best of my knowledge and belief, the information

contained in this disclosure is correct and that I am duly authorised to make this disclosure

by all persons for whom it is made.



Deutsche Craigs Limited

Level 36, Vero Centre

48 Shortland Street

Auckland 1140

New Zealand


Tel: +64 9 913 9090

Fax: +64 9 926 9549




1

20532242_15.docx


STRICTLY PRIVATE & CONFIDENTIAL

16 March 2017


LETTER OF AGREEMENT FOR THE SALE OF SHARES IN THE NEW ZEALAND REFINING

COMPANY LIMITED

1. SALE OF SHARES

1.1 The Sellers wish to sell up to 34,667,381 shares, as set out in Schedule 2, (Sale Shares) in

The New Zealand Refining Company Limited (the Company). Deutsche Craigs Limited, its

affiliates, successors and assigns, as appropriate (DCL) have agreed to use its best

endeavours to procure bids for, and manage the sale of, the Sale Shares (the Sale).

1.2 The Sellers must comply with the timetable set out in the Schedule to this agreement (the

Timetable) (which may be amended by the Sellers with the prior written consent of DCL).

All references to dates in this agreement have the same meaning as in the Timetable and

any defined terms not otherwise defined in this agreement but defined in the Timetable have

the meaning given to them in the Timetable.

BP New Zealand Holdings Limited

Watercare House

73 Remuera Road

Remuera

Auckland, 1050

New Zealand


Europa Oil NZ Limited

Watercare House

73 Remuera Road

Remuera

Auckland, 1050

New Zealand

(each a Seller and, together, the Sellers)


2

20532242_15.docx

1.3 Subject to the terms of this agreement, each Seller agrees to sell its respective Sale Shares

in accordance with the Timetable and DCL will manage the Sale by inviting investors to bid

for the Sale Shares and use its best endeavours to procure purchasers for the Sale Shares

at prices:

(a) at or above a floor price for the Sale Shares in NZ$ (the Floor Price); and

(b) if agreed to by the parties, within a price range for the Sale Shares in NZ$ (the

Agreed Range),

such Floor Price and the Agreed Range (if applicable) to be agreed in writing between the

parties on or before the date of this agreement. Purchasers may include DCL’s related

companies (as that term is defined in the New Zealand Companies Act 1993, read as if the

expression company includes any body corporate, wherever incorporated, each a Related

Company). DCL must agree the initial list of potential cornerstone investors, and any

subsequent potential cornerstone investors, who will be invited to bid for the Sale Shares

with the Sellers in advance of any invitations being made.

1.4 DCL agrees to conduct a bookbuild process (Bookbuild) for the Sale Shares in accordance

with the Timetable. DCL must use its best endeavours to maximise the price of all the Sale

Shares that are to be sold under the Bookbuild. Following the Bookbuild, and prior to

allocation in accordance with clause 1.5, the sale price for the Sale Shares (Sale Price) and

the number of Sale Shares to be sold in the Sale (Sold Shares) will be determined by the

Sellers, after consultation with DCL. The parties agree that:

(a) the Sale Price will not be set:

(i) higher than the price at which DCL has received binding and bona fide offers

from purchasers for all of the Sale Shares which, in the reasonable opinion of

DCL, are capable of acceptance and will, if accepted, result in the formation of

binding agreements for the sale of all of the Sale Shares; or

(ii) lower than the Floor Price; and

(b) the number of Sold Shares will not be set lower than the number of Sale Shares in

respect of which DCL is successful in procuring purchasers at the Sale Price.

1.5 DCL agrees to provide the Sellers with regular updates in relation to the progress of the

Bookbuild, including:

(a) updates on the orders for the Sale Shares obtained throughout the Bookbuild;

(b) the names of the accounts placing orders;

(c) the details of the orders, including sizes of orders, coverage ratios at different prices,

the price of any orders and/or any price limits associated with such orders and the

time of the orders;

(d) such other information as reasonably requested by the Sellers from time to time.


3

20532242_15.docx

1.6 By no later than the Trade Date, the Sellers will determine after consultation with DCL

following the Bookbuild, the allocation of the Sold Shares to persons who have bid for Sale

Shares.

1.7 In consideration of DCL performing its obligations under this agreement, the Sellers agree to

pay to DCL, in their Respective Proportions, fees in accordance with clause 3. For the

purposes of this agreement, the "Respective Proportion" for each Seller equals the Sale

Shares being sold by the Seller divided by the total number of Sold Shares.

1.8 If requested by DCL, the Sellers will approach the Company promptly after this agreement is

signed and request a trading halt with a view to a trading halt being put in place as

contemplated by the Timetable.

1.9 DCL may perform its obligations through Deutsche Bank AG or any branch or Related

Company of DCL, provided that DCL will not engage any advisers without prior consultation

with the Sellers (other than Chapman Tripp, who the parties acknowledge have been

engaged as DCL’s legal advisers by DCL at its own cost).

2. SALE AND PURCHASE OF SALE SHARES

2.1 The sale of the Sold Shares will be effected on the Trade Date in accordance with the

Clearing and Settlement Rules, with settlement to follow on a T+2 basis (the date of

settlement will be referred to as the Settlement Date). Subject to clause 7, on the

Settlement Date, the Sellers shall take all steps reasonably necessary to procure settlement

and DCL shall arrange for the payment to each Seller, or as the Seller directs, of an amount

equal to the Sale Price multiplied by the number of Sold Shares sold by that Seller, less that

Sellers's Respective Proportion of any fees payable under clause 3 by transfer to the

account nominated by that Seller in writing for value (in cleared funds) against delivery of

the respective Sold Shares, provided that DCL shall have no obligation to arrange for

payment to the Sellers, and the Sellers shall have no obligation to deliver the relevant Sold

Shares, to the extent that the settlement of any Sold Shares is not successfully effected with

the purchaser of those Sold Shares by 4.30pm on the Settlement Date.

3. FEES

3.1 In consideration of performing its obligations under this agreement, DCL will be entitled fees

as the parties agree.

3.2 The fees payable under this clause 3 are payable in New Zealand dollars on receipt by the

Sellers of the proceeds of sale of the Sold Shares to which the fees relates and may be

retained by DCL from any amount received as agent, or deducted from any amount which it

is otherwise obliged to pay the Sellers, in respect of that sale.

4. REPRESENTATIONS, WARRANTIES AND UNDERTAKINGS

4.1 Seller

Each Seller represents, warrants and undertakes to DCL in respect of itself only and its Sale

Shares (as set out alongside its name in Schedule 2) only at the date of this agreement and

on each date until and including the Settlement Date that each of the following statements is

true, accurate and not misleading:


4

20532242_15.docx

(a) Body corporate: it is a body corporate validly existing and duly established under the

laws of its place of incorporation;

(b) Capacity: the Seller has full legal capacity and power to enter into this agreement

and to carry out the transactions that this agreement contemplates;

(c) Authority: the Seller has taken all corporate action that is necessary or desirable to

authorise its entry into this agreement and its carrying out of the transactions that this

agreement contemplates and it has the appropriate authorities to enter into and

perform its obligations under this agreement;

(d) Agreement effective: this agreement constitutes the Seller’s legal, valid and binding

obligations, enforceable against it in accordance with its terms;

(e) Sole owner, no encumbrance: the Seller is the holder and sole legal and beneficial

owner of the Sale Shares and owns the Sale Shares free and clear of all liens,

charges, security interests, claims, equities and pre-emptive rights;

(f) Shares rank equally: following sale by the Seller, the Sale Shares will rank equally in

all respects with all other outstanding ordinary shares of the Company, including their

entitlement to dividends;

(g) Power to sell: the Seller has the corporate authority and power to sell the Sale

Shares under this agreement and no person has a conflicting right, whether

contingent or otherwise, to purchase or to be offered for purchase the Sale Shares,

or any of them;

(h) No offer document required: the Sale Shares may be offered under the Sale (and

may be offered after the Sale) without disclosure to investors in New Zealand under

the Financial Markets Conduct Act 2013 (the FMCA) and, in particular, none of

clauses 31 to 34 of Schedule 1 of the FMCA will apply in respect of the offer of Sale

Shares by the Seller and managed by DCL contemplated by this agreement and that

offer will not be an offer of financial products for sale that requires disclosure under

Part 3 of the FMCA;

(i) Information true and correct: all information provided by the Seller to DCL, whether

verbally or in writing, in relation to the Sale is true and correct in all material respects

and not misleading or deceptive, whether by omission or otherwise in any material

respect;

(j) No contravention: compliance by the Seller with all of the provisions of this

agreement will not conflict with, result in a breach or violation of, or constitute a

default under:

(i) any agreement or instrument to which the Seller is a party or by which it or

any of its properties or assets are bound; or

(ii) any statute, rule or regulation applicable to, or any order of any court or

governmental agency with jurisdiction over, the Seller, its assets or its

properties;


5

20532242_15.docx

(k) No inside information: the Seller (excluding any knowledge of any of its directors,

officers or employees who are not involved in or aware of the Sale) does not at the

date of this agreement have any information relating to the Company or its securities

that is not generally available to the market, that a reasonable person would expect,

if it were generally available to the market, to have a material effect on the price of

the Company’s quoted securities (other than knowledge that it proposes to enter into

this agreement and the transactions contemplated by it), and the Sale will not

constitute a violation by the Seller of applicable insider trading laws for which there is

no applicable defence;

(l) Chinese Walls: in relation to the Sale, the Seller is able to rely upon the defence set

out in, and is satisfying the requirements of, section 261(1) of the FMCA;

(m) No stabilisation or manipulation: neither the Seller nor any of its Affiliates has taken

or will take, directly or indirectly, any action designed to, or that might reasonably be

expected to, cause or result in the stabilisation or manipulation of the price of the

Sale Shares in violation of any applicable law;

(n) NZX listing: the Sale Shares are quoted on the financial market operated by NZX

Limited known as the NZX Main Board;

(o) No general solicitation or general advertising: none of the Seller, any of its affiliates

(as that term is defined in Rule 501 under the US Securities Act of 1933 (the US

Securities Act)) (Affiliates), any person acting on behalf of any of them (other than

DCL or its Affiliates or any person acting on behalf of any of them, as to whom the

Seller makes no representation) has offered or sold, or will offer or sell, any Sale

Shares in the United States using any form of “general solicitation” or “general

advertising” within the meaning of Rule 502(c) under the US Securities Act; and

(p) No directed selling efforts: with respect to those Sale Shares sold, or to be sold, in

reliance on Regulation S under the US Securities Act (Regulation S), none of the

Seller, any of its Affiliates, any person acting on behalf of any of them (other than

DCL or its Affiliates or any person acting on behalf of any of them, as to whom the

Seller makes no representation) has engaged or will engage in any “directed selling

efforts” (as that term is defined in Rule 902(c) under the US Securities Act) and each

of the Seller, its Affiliates, and any person acting on behalf of any of them (other than

DCL or its Affiliates or any person acting on behalf of any of them, as to whom the

Seller makes no representation) has complied and will comply with the offering

restrictions requirement of Regulation S.

For the purposes of this clause 4.1, the term Affiliate does not include (i) the Seller and its

Affiliates other than the Seller and its Affiliates that it controls or (ii) the Company and its

Affiliates that it controls.

4.2 Deutsche Craigs Limited

DCL represents, warrants and undertakes to the Sellers at the date of this agreement and

on each date until and including the Settlement Date, in respect of itself, Deutsche Bank AG

and any branch or Related Company of DCL which performs DCL's obligations under this

agreement in accordance with clause 1.9, that each of the following statements is correct:


6

20532242_15.docx

(a) Body corporate: it is a body corporate validly existing and duly established under the

laws of its place of incorporation;

(b) Capacity: it has full legal capacity and power to enter into this agreement and to

carry out the transactions that this agreement contemplates;

(c) Authority: it has taken all corporate action that is necessary or desirable to authorise

its entry into this agreement and its carrying out of the transactions that this

agreement contemplates and it has the appropriate licensing, permits and authorities

to enter into and perform its obligations under this agreement;

(d) Agreement effective: this agreement constitutes its legal, valid and binding obligation,

enforceable against it in accordance with its terms;

(e) Compliance: it and its Affiliates will perform their obligations under this agreement,

and the Sale will be conducted by it and its Affiliates (including the making of each

offer or invitation to acquire Sale Shares), in accordance with all applicable laws and

regulations in any relevant jurisdiction, including without limitation any applicable

trade sanction or anti-money laundering laws or regulations, provided that there shall

not be a breach of this warranty to the extent any breach is caused by an act or

omission which constitutes a breach by a Seller of its representations, warranties and

undertakings in clause 4.1 or to the extent that an offer or invitation is made to a

person in a jurisdiction listed in Section 5 of Schedule 4 of the Master ECM Terms

published by the New Zealand Financial Markets Association whom DCL reasonably

believes having followed the practice typically complied with by investment banks of

international standing in connection with a transaction of this nature in the relevant

jurisdiction, to be a person who is able to give the warranties and representations

listed in that Section for the relevant jurisdiction and those set out under the heading

“Regulation S Offer - Category 1 – excluding Eligible U.S. Fund Managers” in Section

2 of that Schedule;

(f) Status: it is a “qualified institutional buyer” (as defined in Rule 144A under the US

Securities Act (QIB)) or is not a “US person” (as defined in Rule 902(k) under the US

Securities Act);

(g) No US registration: it acknowledges that the Sale Shares have not been registered

and will not be registered under the US Securities Act and they undertake to offer

and sell the Sale Shares only in accordance with (i) the provisions of Rule 903 or

Rule 904 under the US Securities Act and (ii) Rule 144A under the US Securities Act;

(h) No solicitation: it, its Affiliates and any person acting on behalf of any of it, has not

solicited offers for or offered to sell, and will not solicit offers for, or offer or sell, the

Sale Shares in the “United States” (as defined in Rule 902(l) under the US Securities

Act) using any form of “general solicitation” or “general advertising” within the

meaning of Rule 502(c) under the US Securities Act;

(i) Broker-dealer requirements: all offers and sales of Sale Shares in the United States

by it and any of its Affiliates will be effected in accordance with all applicable US

broker-dealer requirements;


7

20532242_15.docx

(j) Non-US offers: it, its Affiliates and any person acting on its behalf has offered the

Sale Shares, and will offer and sell the Sale Shares, only in offshore transactions (as

defined in Rule 902(h) under the US Securities Act) in compliance with Regulation S.

With respect to those Sale Shares sold or to be sold in reliance on Regulation S,

none of DCL, its Affiliates nor any person acting on behalf of any of them has

engaged or will engage in any “directed selling efforts” (as that term is defined in

Rule 902(c) under the US Securities Act); and

(k) No stabilisation or manipulation: none of DCL or any of its Affiliates or any person

acting on behalf of any of them has taken or will take, directly or indirectly, any action

designed to, or that might reasonably be expected to, cause or result in the

stabilisation or manipulation of the price of any security of the Company to facilitate

the sale or resale of the Sale Shares in violation of any applicable law.

4.3 Representations and warranties continue in force

The above representations and warranties continue in full force and effect notwithstanding

completion of this agreement.

4.4 Acknowledgement of reliance on representations and warranties

The party or parties giving the above representations and warranties acknowledge that the

other party or parties have relied on these representations and warranties in entering into

this agreement and will rely on these representations and warranties in performing their

respective obligations under this agreement.

4.5 Notification

Each party agrees that it will tell the other parties promptly upon becoming aware of any of

the following occurring prior to the completion of the sale of the Sale Shares:

(a) any material change affecting any of the foregoing representations and warranties; or

(b) any of the foregoing representations or warranties becoming materially untrue or

materially incorrect.

5. UNDERTAKINGS OF THE SELLERS

5.1 The Sellers must not, prior to the settlement of purchases in accordance with this

agreement and the Clearing and Settlement Rules, commit, be involved in or acquiesce to

any activity in relation to the Sale which breaches:

(a) the FMCA or the Takeovers Code Approval Order 2000;

(b) any other applicable laws or regulations in New Zealand or otherwise;

(c) the listing rules of NZX;

(d) its constitution; or

(e) any legally binding requirement of the Financial Markets Authority (FMA) or the NZX;

and


8

20532242_15.docx

in each case to the extent such breach impacts or could reasonably be expected to impact

on the sale of the Sale Shares, this agreement or the Company, each of these undertakings

being material terms of this agreement.

6. INDEMNITY

6.1 The Sellers will keep DCL, Craigs Investment Partners Limited, Deutsche Bank AG and

their Related Companies and their respective directors, officers, partners, employees,

representatives and agents (Indemnified Parties) indemnified against any losses, damages,

liabilities, costs, claims, actions and demands (including any properly incurred expenses

arising in connection therewith) (Losses) sustained or incurred in connection with this

agreement, the Sale or any breach of this agreement by the Sellers (including any breach of

any of the above representations or warranties given by the Sellers) and will reimburse an

Indemnified Party for all reasonable and properly incurred out of pocket costs, charges and

expenses which it may properly pay or incur in connection with investigating, disputing or

defending in good faith and on reasonable grounds any such action, demand or claim for

which it is indemnified under this agreement.

6.2 The indemnity in clause 6.1 does not extend to and is not to be taken as an indemnity

against any Losses of an Indemnified Party to the extent those Losses result from:

(a) any fraud, recklessness, wilful misconduct or negligence of that Indemnified Party as

determined by a judgment of a Court of competent jurisdiction;

(b) any penalty or fine which the Indemnified Party is required to pay for any

contravention of any law; or

(c) any amount in respect of which the indemnity would be illegal, void or unenforceable

under applicable law as determined by a judgment of a Court of competent

jurisdiction; or

(d) each party paying its own out of pocket costs and expenses (including any advisers'

fees and bookbuild software usage costs) incurred by it in connection with this

agreement or the Sale.

6.3 If DCL becomes aware of any suit, action, investigation, proceedings, demand or claim in

respect of which an Indemnified Party wishes to claim for indemnification under the

indemnity contained in this clause 6, DCL must promptly notify the Sellers of the substance

of that matter. The failure of DCL to notify the Sellers pursuant to this clause will not release

the Sellers from any obligation or liability which they may have pursuant to this agreement

except that such liability will be reduced to the extent to which the amount the subject of the

indemnity under clause 6 has increased, as a result of the failure to so notify.

6.4 An Indemnified Party must not admit liability in respect of all or part of, or settle,

compromise, consent to the entry of any judgment in or otherwise seek to terminate any

suit, action, investigation, proceeding, demand or claim to which the indemnity in clause 6.1

relates without the prior written consent of the Sellers, such consent not to be unreasonably

withheld.


9

20532242_15.docx

6.5 The indemnity in clause 6.1 is a continuing obligation, separate and independent from the

other obligations of the parties under this agreement and survives termination or completion

of this agreement. It is not necessary for an Indemnified Party to incur expense or make

payment before enforcing that indemnity, provided always that DCL shall repay to the

Sellers all amounts received under the indemnity to the extent that such amount exceeds

the amount of any Losses actually incurred or paid by DCL.

6.6 The parties agree that, for the purposes of the Contracts (Privity) Act 1982, the indemnity in

clause 6.1 (as limited by clause 6.2) is intended to confer a benefit on, and be enforceable

by, each Indemnified Party (provided that this agreement may be varied by the parties to it

without the consent of any Indemnified Party).

7. TERMINATION EVENTS

7.1 Termination events

DCL may, without costs or liability, terminate its obligations under this agreement by giving

written notice to the Sellers at any time, up to and including, 10.00am on the Settlement

Date in any of the following circumstances:

(a) a Seller contravenes any applicable provisions of the FMCA or any other applicable

laws or regulations in New Zealand or otherwise or any requirement of the FMA or

the NZX, other than to the extent that the Seller has the benefit of a waiver or

exemption under applicable laws or a defence under section 261(1) of the FMCA in

relation to any such provision or regulation or requirement;

(b) the FMA issues or threatens to issue proceedings in relation to the Sale or

commences, or threatens to commence any inquiry or investigation in relation to the

Sale (other than in respect of the actions of DCL where such actions are not

contemplated by this agreement);

(c) the NZX suspends trading of ordinary shares in the Company on the NZX Main

Board, unless as contemplated by clause 1.8 or otherwise only as a consequence or

in contemplation of the Sale, either by their own initiative or at the request of the

Company or the NZX removes the Company from the official list of NZX, or the NZX

announce any intention to do any of the foregoing;

(d) a Seller defaults in the performance of any of its obligations under this agreement; or

(e) a representation, warranty or undertaking given by a Seller in this agreement is not

true or correct,

provided that DCL may only terminate its obligations in any of the above circumstances if, in

its reasonable opinion, the circumstances or combinations thereof:

(f) have or would reasonably be expected to have, a material adverse effect on:

(i) the willingness of persons to purchase the Sale Shares; or

(ii) the price at which ordinary shares in the Company are traded on the NZX

Main Board; or


10

20532242_15.docx

(g) would reasonably be expected to give rise to a material liability for an Indemnified

Party under the FMCA or other applicable law.

7.2 Effect of termination

Subject to clause 6.5, if this agreement is terminated, neither DCL nor the Sellers will have

any obligations under this agreement. Any termination of this agreement will be without

prejudice to any accrued rights or obligations arising before or in relation to such

termination.

8. PUBLICITY

The Sellers and DCL will consult with each other in respect of any material public releases

by any of them concerning the Sale. The prior written consent of the other party (such

consent not to be unreasonably withheld or delayed) must be obtained prior to any party

making any release or announcement or engaging in publicity in relation to the Sale on or

before the Settlement Date, and such release, announcement or engagement must be in

compliance with all applicable laws, including the securities laws of New Zealand and any

other jurisdiction.

9. SELLERS' REPRESENTATIVE

9.1 The Sellers agree that when this agreement provides that any power may be exercised by,

any decision may be made by, any action may be performed by, any notice may be given

by, or any consent may be given by the Sellers:

(a) then, without releasing Europa Oil NZ Limited from any obligation hereunder, that

power may be exercised by, that decision may be made by, that action may be

performed by, that notice may be given by and that consent may be given by BP

New Zealand Holdings Limited (Sellers' Representative) for and on behalf of Europa

Oil NZ Limited; and

(b) DCL may rely (without further inquiry or action by them) on the exercise, decision,

determination, action, notice or consent of the Sellers' Representative notified to

them by the Sellers' Representative in relation to any such matters, unless the

Sellers otherwise notify DCL in writing prior to DCL relying in the exercise, decision,

determination, action, notice or consent of the Sellers' Representative.

9.2 Europa Oil NZ Limited irrevocably agrees to be bound by all acts and omissions of the

Sellers' Representative in exercising its rights and, as relevant, performing the obligations

under this agreement.

10. NOTICES

A notice, approval, consent or other communication in connection with this agreement must

be:

(a) in writing;

(b) marked for the attention of the person specified in this clause; and


11

20532242_15.docx

(c) left at the address of the addressee, or sent by email to the email address of the

addressee which is specified in this clause or if the addressee notifies another

address or email address then to that address or email address.

The address, email address and addressee of each party is:

The Sellers

Address: Watercare House

73 Remuera Road

Remuera

Auckland 1050

New Zealand

Email: Peter Knipping@se1.bp.com

Attention: Peter Knipping

With a copy to:

Attention: Patrick Halpin

Email: patrick.halpin@uk.bp.com

and

Attention: Jonathan Mills

Email: jonathan.mills@uk.bp.com

DCL

Deutsche Craigs Limited

Address: Level 36

Vero Centre

48 Shortland Street

Auckland 1010

New Zealand


Email: jeremy.williamson@deutschecraigs.com

Attention: Jeremy Williamson

A notice, approval, consent or other communication takes effect from the time it is received

unless a later time is specified in it, but if it is received after 5.00pm in the place of receipt or

on a non-business day in that place, it is to be deemed received at 9.00am on the next

business day in that place. A notice, approval, consent or other communication is shall be

deemed to have been received, if sent by email, four business hours after the time sent (as

recorded on the device from which the sender sent the email) unless the sender receives an

automated message that the email has not been delivered.


12

20532242_15.docx

11. GENERAL

11.1 Governing Law

The laws of New Zealand shall govern this agreement. The parties submit to the non-

exclusive jurisdiction of the New Zealand courts.

11.2 Severability

Each provision of this agreement is severable. If the whole or part of any provision is or

becomes void, unenforceable or illegal in a jurisdiction, it is severed for that jurisdiction. The

remaining provisions will not be affected.

11.3 Entire Agreement

This agreement comprises the entire agreement between the parties in relation to its subject

matter and supersedes all previous understandings, agreements or arrangement whether

written or oral.

11.4 Waiver and Variation

A provision of or a right created under this agreement may not be:

(a) waived except in writing signed by the party granting the waiver; or

(b) varied except in writing signed by the parties.

11.5 Remedies Cumulative

The rights, powers and remedies provided in this agreement are cumulative with and not

exclusive of the rights, powers or remedies provided by law independently of this

agreement.

11.6 Assignment

The rights and obligations of each party under this agreement cannot be assigned without

the prior written consent of the others.

11.7 Counterparts

This agreement may be executed in any number of counterparts and all counterparts taken

together will be regarded as one instrument.

11.8 Further Assurances

Each party agrees, at its own expense, on the request of the other parties, to do everything

reasonably necessary to give effect to this agreement and the transactions contemplated by

it, including, but not limited to, the execution of documents.

11.9 Approvals and Consents

A party may give conditionally or unconditionally or withhold its approval or consent in its

absolute discretion unless this agreement expressly provides otherwise.

11.10 Time

All dates and times referred to in this agreement are New Zealand dates and times.


15

20532242_15.docx

SCHEDULE 1: TIMETABLE

Execute Agreement By 5.00pm, 16 March 2017

Book opens By 5.05pm, 16 March 2017

Trading halt commences By 9.30am, 17 March 2017

Book closes and Sale Price determined On or around 10.00am, 17 March 2017

Trading halt ceases On or around 2.00pm, 17 March 2017

Trade Date 17 March 2017

Settlement Date (T+2) 21 March 2017



16

20532242_15.docx

SCHEDULE 2: SALE SHARES

Seller Number of Sale Shares

BP New Zealand Holdings Limited 10,667,367

Europa Oil NZ Limited 24,000,014

TOTAL

34,667,381

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.